Stem Cell Reports Biology of Human Primary Bone Marrow Mesenchymal Stromal Stem Cells Human Bone Marrow Mesenchymal Stromal Stem Cells in He
Stem Cell Reports Biology of Human Primary Bone Marrow Mesenchymal Stromal Stem Cells Human Bone Marrow Mesenchymal Stromal Stem Cells in Health and Disease. 3(6):965-974
Subject Terms:
Medical and Health Sciences, Basic Medicine, Cell and Molecular Biology, Medicin och hälsovetenskap, Medicinska och farmaceutiska grundvete
Human bone marrow (BM) contains a rare population of nonhematopoietic mesenchymal stromal cells (MSCs), which are of central importance for
Human bone marrow (BM) contains a rare population of nonhematopoietic mesenchymal stromal cells (MSCs), which are of central importance for the hematopoietic microenvironment. However, the precise phenotypic definition of these cells in adult BM has not yet been reported. In this study, we show that low/negative expression of CD140a (PDGFR-α) on lin(-)/CD45(-)/CD271(+) BM cells identified a cell population with very high MSC activity, measured as fibroblastic colony-forming unit frequency and typical in vitro and in vivo stroma formation and differentiation capacities. Furthermore, these cells exhibited high levels of genes associated with mesenchymal lineages and HSC supportive function. Moreover, lin(-)/CD45(-)/CD271(+)/CD140a(low/-) cells effectively mediated the ex vivo expansion of transplantable CD34(+) hematopoietic stem cells. Taken together, these data indicate that CD140a is a key negative selection marker for adult human BM-MSCs, which enables to prospectively isolate a close to pure population of candidate human adult stroma stem/progenitor cells with potent hematopoiesis-supporting capacity.
Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of stem cell research, Stem Cell Center, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för stamcellsforskning, Stamcellscentrum (SCC), Originator, Lund University, Faculty of Medicine, Department of Laboratory Medicine, Division of Molecular Hematology (DMH), Bone marrow stem cells and cellular therapies, Lunds universitet, Medicinska fakulteten, Institutionen för laboratoriemedicin, Avdelningen för molekylär hematologi, Benmärgsstamceller och cellulära terapier, Originator, Lund University, Profile areas and other strong research environments, Strategic research areas (SRA), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Lunds universitet, Profilområden och andra starka forskningsmiljöer, Strategiska forskningsområden (SFO), StemTherapy: National Initiative on Stem Cells for Regenerative Therapy, Originator